NEW YORK (GenomeWeb) – Response Genetics reported today a roughly 3 percent drop in its first quarter revenues as an increase in test order volume was offset by lower reimbursement.

The Los Angeles-based molecular diagnostic testing services firm reported total revenues of $3.8 million for the three months ended March 31, down from $3.9 million in Q1 2014. It said that sales associated with its ResponseDx tests were $3.3 million, consistent with the first quarter of 2014. However, its pharmaceutical client revenue slipped to $500,000 from $600,000 year over year.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

What happens to scientific papers when certain journals are no longer published? Some scientists are trying to make sure they don't disappear forever.

A study in Microbiome finds that heavy drinkers have an unhealthy mix of bacteria in their mouths.

Doctors and patients are still trying to figure out what role at-home genetic testing should play in healthcare, Newsweek says.

In Genome Research this week, mismatch repair deficiency in C. elegans, retracing transcriptions start site evolution in the human genome, and more.